
|Articles|June 29, 2012
Schizophrenia Pharmacotherapy: What Role for Perphenazine? (Video 1:39 minutes)
Author(s)Peter F. Buckley, MD
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.
Advertisement
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.
Perphenazine was used in the CATIE study. Here, Dr. Peter Buckley addresses:
• The current role of perphenazine in the management of schizophrenia.
• The drug’s association with weight gain.
• The metabolic side effect profile of perphenazine.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
2
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
3
Zervimesine May Slow Progression of Dementia With Lewy Bodies, Phase 2 Results Show
4
Accident, or Is It? The Watershed Area Between Trauma and Suicide
5

















